SCHEMBL31360909

SCHEMBL31360909

Cn1cc(C2CN(c3cnc([N+](=O)[O-])c(Br)c3)CCO2)cn1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.34
MAPT P10636 3/20 0.33
RAB9A P51151 1/20 0.33
CYP2D6 P10635 4/20 0.32
GSK3B P49841 4/20 0.32
CYP1A2 P05177 3/20 0.32
CSNK1A1 P48729 1/20 0.32
GSK3A P49840 1/20 0.32
P2RX7 Q99572 3/20 0.32
MET P08581 4/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
KCNH2 Q12809 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
PDE10A Q9Y233 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31360827 0.82 CHRNB2 (0.34) P2RX7METPDE3BPDE3APDE10A
SCHEMBL26988872 0.80 P2RX7 (0.33) MAPTCYP2D6GSK3BCYP1A2P2RX7
SCHEMBL30722815 0.80 P2RX7 (0.33) MAPTCYP2D6GSK3BCYP1A2P2RX7
SCHEMBL30722734 0.78 SIRT6 (0.37) MAPTP2RX7KCNH2
SCHEMBL26988396 0.78 SIRT6 (0.37) MAPTP2RX7KCNH2
SCHEMBL359423 0.74 POLB (0.56) POLBMAPTCYP2D6CYP1A2ALDH1A1
SCHEMBL31360856 0.71 P2RX7 (0.34) CYP2D6GSK3BCYP1A2CSNK1A1GSK3A
SCHEMBL31425103 0.69 EIF2AK4 (0.38) CYP2D6GSK3BCYP1A2P2RX7PDE10A
SCHEMBL16684517 0.69 POLB (0.49) POLBMAPTCYP1A2ALDH1A1CYP2C9
SCHEMBL26340591 0.67 DRD3 (0.36) CYP2D6GSK3BP2RX7KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747249-A1 TREM2 MODULATORS Muna Therapeutics ApS (DK) 2026-05-27 EP disclosed
WO-2025017059-A1 TREM2 MODULATORS MUNA THERAPEUTICS APS (DK) 2025-01-23 WO disclosed